CurrentCardio
Get Weekly

Topic · page 25 of 49

Heart failure & cardiomyopathies

HFrEF, HFmrEF, HFpEF, acute HF, cardiomyopathies (HCM, DCM, amyloidosis), myocarditis and inflammatory cardiomyopathy, devices for HF, HF prognosis

Briefs 961–1,000 of 1,928 placed here, newest publication first

Briefs in Heart failure & cardiomyopathies

Newest publication first

  1. Circulation

    Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure

    Randomised controlled trial

  2. Eur J Prev Cardiol

    Pneumococcal vaccination incentive campaign in chronic heart failure patients in France: a cluster-randomized trial

    Randomised controlled trial

  3. Eur Heart J

    Surgical myectomy for hypertrophic cardiomyopathy: procedural volume and outcomes

    Cohort study

  4. Eur J Prev Cardiol

    Peripheral vs. central arterial stiffness and cardiovascular events in older adults: the Atherosclerosis Risk in Communities study

    Cohort study

  5. J Am Coll Cardiol

    A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular Risk

    Cohort study

  6. J Am Coll Cardiol

    Echocardiographic Changes With Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy: Exploratory Insights From the ODYSSEY-HCM Trial

    Secondary analysis

  7. J Am Coll Cardiol

    Effects of Mavacamten on Cardiac Biomarkers in Nonobstructive Hypertrophic Cardiomyopathy: Insights From the ODYSSEY-HCM Trial

    Secondary analysis

  8. JACC Cardiovasc Imaging

    Mechanical Wave Analysis at High Frame-Rate Echocardiography: Feasibility, Determinants, and Normal Ranges

    Cross-sectional study

  9. J Am Coll Cardiol

    Effect of Vericiguat on Total Heart Failure Events in Compensated Outpatients With HFrEF: Insights From VICTOR

    Secondary analysis

  10. J Am Coll Cardiol

    Trade-Off Between Bleeding and Ischemic Events From Left Ventricular Assist Devices: A EUROMACS Registry Analysis

    Cohort study

  11. J Am Coll Cardiol

    Natriuretic Peptides, Body Mass Index, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

    Meta-analysis

  12. J Am Coll Cardiol

    Adiposity-Related Anthropometrics and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Participant-Level Pooled Analysis of Randomized Clinical Trials

    Meta-analysis

  13. J Am Coll Cardiol

    Effect of Aficamten Compared With Metoprolol on Echocardiographic Measures in Symptomatic Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM

    Secondary analysis

  14. Eur J Heart Fail

    Randomized Investigation of Heart Failure Therapy in Patients with Advanced Cancer at Risk of Cardiac Wasting: Rationale and Design of the EMPATICC Trial

    Trial design

  15. Eur J Heart Fail

    Diuretic Resistance and the Efficacy of Hydrochlorothiazide in Acute Decompensated Heart Failure: A Post-Hoc Analysis of the CLOROTIC Trial

    Secondary analysis

  16. J Am Coll Cardiol

    Evidentiary Landscape of Heart Failure Therapies, Regulatory Decisions, and Translation Into Guidelines

    Research article

  17. JACC Heart Fail

    Temporal Changes in Biomarkers, Functional Status, and Quality of Life Prior to Adverse Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

    Secondary analysis

  18. Europace

    Conduction system pacing versus biventricular pacing for cardiac resynchronization: the CSP-SYNC randomized single center study

    Randomised controlled trial

  19. JACC Heart Fail

    Contemporary Antibody-Mediated Rejection in Heart Transplantation: JACC: Heart Failure Position Statement

    Guideline or statement

  20. JACC Heart Fail

    Disease Penetrance in Genotype-Positive But Clinically Unaffected Relatives From Families With Dilated Cardiomyopathy

    Cohort study

  21. JACC Heart Fail

    Clinical Presentation, Biomarker Trajectories, and Outcomes in Women and Men Hospitalized for Acute Heart Failure

    Secondary analysis

  22. Circulation

    Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants

    Cohort study

  23. JACC Heart Fail

    Achieved Ejection Fraction and Effects of Dapagliflozin in Heart Failure With Improved Ejection Fraction

    Secondary analysis

  24. Eur J Heart Fail

    Heart Failure-Attributed Mortality in Europe, 2012–2021

    Cohort study

  25. Eur J Heart Fail

    Identifying and Overcoming Barriers to Referral in Advanced Heart Failure. A Scientific Statement of the Heart Failure Association (HFA) of the ESC

    Guideline or statement

  26. Eur J Heart Fail

    Clustering in Dilated Cardiomyopathy at Initial Evaluation: An Effective Tool for Clinical Stratification

    Cohort study

  27. Eur J Heart Fail

    Real-Life Implementation of Guideline-Recommended Medical Therapy in Heart Failure with Reduced Ejection Fraction: Effects on Prognosis and Left Ventricular Ejection Fraction. Primary results of TITRATE-HF

    Cohort study

  28. Eur J Prev Cardiol

    Pharmacological treatment patterns and outcomes according to the coexistence of heart failure and Type 2 diabetes: data from the Swedish Heart Failure Registry and National Diabetes Registry

    Cohort study

  29. JAMA Cardiol

    Efficacy and Tolerability of Finerenone According to the Use and Dosage of Diuretics: A Prespecified Analysis of the FINEARTS-HF Randomized Clinical Trial

    Secondary analysis

  30. JACC Heart Fail

    Early Reduction of Pulmonary Artery Pressures Is Associated With Improved Mortality Among Medicare Beneficiaries With Heart Failure

    Cohort study

  31. J Am Coll Cardiol

    Effects of Vutrisiran on Cardiac Function and Outcomes in Patients With Transthyretin Amyloidosis With Cardiomyopathy

    Secondary analysis

  32. Eur Heart J

    Withdrawal of heart failure therapy after atrial fibrillation rhythm control with ejection fraction normalization: the WITHDRAW-AF trial

    Randomised controlled trial

  33. Eur J Heart Fail

    Management of Patients with Heart Failure at High Risk of Hyperkalaemia: The CARE-HK in HF Registry

    Cohort study

  34. Eur J Heart Fail

    A Multicentre, Randomized, Double-Blind, Active and Placebo-Controlled Study of Pecavaptan, a Dual V1a/V2 Vasopressin Receptor Antagonist, in Patients with Acute Heart Failure: The AVANTI Trial

    Randomised controlled trial

  35. Eur J Heart Fail

    Rationale and Design of the TRIC-I-HF-DZHK24 (TRICuspid Intervention in Heart Failure) Trial

    Trial design

  36. Europace

    Premature ventricular contraction–induced ventricular dysfunction in children without structural heart disease: a systematic review and meta-analysis

    Meta-analysis

  37. Eur Heart J

    Titin-related familial dilated cardiomyopathy: factors associated with disease onset

    Cohort study

  38. JACC Heart Fail

    Identifying Predictors for Heart Failure Outcomes in Phospholamban p.(Arg14del)–Positive Individuals

    Cohort study

  39. Eur J Prev Cardiol

    Cardiopulmonary exercise testing in hypertrophic cardiomyopathy: the role of reduced O2 pulse and chronotropic incompetence in myocardial adaptation

    Cohort study

  40. Nat Med

    Effects of vutrisiran on cardiac structure and function in patients with transthyretin amyloidosis with cardiomyopathy: secondary outcomes of the HELIOS-B trial

    Secondary analysis

All 1,928 Briefs in ExploreShowing Briefs 961–1,000 of 1,928, newest first